Effective Assessment of Rheumatoid Arthritis Disease Activity and Outcomes Using Monocyte Chemotactic Protein-1 (MCP-1) and Disease Activity Score 28-MCP-1
International Journal of Molecular Sciences · 23.10.2024 · 25 (21) · 11374
DOI: 10.3390/ijms252111374 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.10.2024. Verfasst von Ping-Han Tsai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Allergy, and Immunology, New Taipei Municipal Tucheng Hospital, New Taipei City 236, Taiwan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Chemokine CCL2, Severity of Illness Index, Antirheumatic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Medical Foundation, Taiwan, Chang Gung Medical Foundation.
Abstract (Originalsprache)
The effectiveness of monocyte chemotactic protein-1 (MCP-1) and Disease Activity Score 28 (DAS28)-MCP-1 (DAS28-MCP-1) in assessing rheumatoid arthritis (RA) disease activity is unclear, although some studies have demonstrated their potential usefulness. The present study investigated relationships between MCP-1 and different DAS28 measures, the occurrence of residual swollen joints in different DAS28 remission statuses, changes in medication dosage in relation to the 2005 modified American Rheumatism Association and 2011 American College of Rheumatology/European League against Rheumatism (ACR/EULAR) remission definitions, and the correlations between different DAS28-related scores and Health Assessment Questionnaire Disability Index (HAQ-DI) scores in two RA patient cohorts. The results revealed that the MCP-1 level was correlated with five disease activity measures (DAS28-erythrocyte sedimentation rate [DAS28-ESR], DAS28-C-reactive protein [CRP], Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), and DAS28-MCP-1) in multivariable regression analysis (all p < 0.05; ESR, CRP, and MCP-1 as independent variables). However, ESR was not significantly associated with SDAI and CDAI scores (p = 0.343 and 0.323, respectively). Residual swollen joints were more frequently observed in patients who met the DAS28-ESR remission criteria (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Allergy, and Immunology, New Taipei Municipal Tucheng Hospital, New Taipei City 236, Taiwan.
- Division of Rheumatology, Allergy, and Immunology, Chang Gung Memorial Hospital at Linkou, Taoyuan City 333, Taiwan.
- School of Medicine, Chang Gung University College of Medicine, Taoyuan City 333, Taiwan.
ORCID-Profile: Ping-Han Tsai, Lieh-Bang Liou
Förderung
- Chang Gung Medical Foundation, Taiwan
- Chang Gung Medical Foundation
Zitieren
APA
Tsai, P. H., & Liou, L. B. (2024). Effective Assessment of Rheumatoid Arthritis Disease Activity and Outcomes Using Monocyte Chemotactic Protein-1 (MCP-1) and Disease Activity Score 28-MCP-1. International Journal of Molecular Sciences, 25(21), 11374. https://doi.org/10.3390/ijms252111374
Vancouver
Tsai PH, Liou LB. Effective Assessment of Rheumatoid Arthritis Disease Activity and Outcomes Using Monocyte Chemotactic Protein-1 (MCP-1) and Disease Activity Score 28-MCP-1. International Journal of Molecular Sciences. 2024;25(21):11374. doi:10.3390/ijms252111374
BibTeX
@article{Tsai2024,
author = {Tsai, Ping-Han and Liou, Lieh-Bang},
title = {Effective Assessment of Rheumatoid Arthritis Disease Activity and Outcomes Using Monocyte Chemotactic Protein-1 (MCP-1) and Disease Activity Score 28-MCP-1},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {21},
pages = {11374},
doi = {10.3390/ijms252111374}
}
EUVIMED